Pharmaceutical Industry

Drug makers are under fire as the $84,000 price tag on a new hepatitis medicine has galvanized the debate over prescription drug costs. But the pharmaceutical industry could be mounting a much stronger defense if it weren't haunted by its support for government health care. (Thinkstock Image)

Columnists

Pharmaceutical industry haunted by support for government health care

Philip Klein -

May 29, 2014 9:56 pm

Business

Pfizer pulls plug on push to buy AstraZeneca

Alex Veiga -

May 26, 2014 6:29 pm

Business

FDA approves new antibiotic for skin infections

Washington Examiner -

May 23, 2014 8:55 pm

FILE - This Friday May 2, 2014 file photo shows an exterior view of the Two Kingdom Street building which houses the headquarters of AstraZeneca, in the Paddington area of London. The board of AstraZeneca has rejected the improved $119 billion takeover offer from U.S. drugmaker Pfizer, Monday May 19, 2014, a decision that has caused a sharp slide in the U.K. company's share price as investors think it effectively brings an end to the protracted and increasingly bitter takeover saga. (AP Photo/Matt Dunham, File)

Business

AstraZeneca rejects $119 billion offer from Pfizer

Washington Examiner -

May 19, 2014 4:14 pm

Business

CEO of China drug maker jumps to death amid probe

Washington Examiner -

May 19, 2014 1:43 pm

Business

Pfizer raises offer, highlighting flurry of deals

The Associated Press -

May 19, 2014 8:25 am

Business

Pfizer ups offer for AstraZeneca again, to $119B

Linda Johnson -

May 19, 2014 4:06 am

Business

Bayer sells division to Boston Scientific

Washington Examiner -

May 15, 2014 11:59 am

Business

Chinese police accuse British executive of drug maker GSK of ordering staff to bribe doctors

Washington Examiner -

May 14, 2014 3:22 am

Business

Pfizer chief says jobs will go in takeover

Danica Kirka -

May 13, 2014 3:44 pm

1...147148149...156 Page 148 of 156

Tag: Pharmaceutical Industry